Building on APACMed’s advocacy work on the “Value of Diagnostics”, this paper aims to continue highlighting the substantial value in-vitro diagnostics provide to patients, healthcare professionals, providers/laboratory professionals, policy-makers and payers in the Asia Pacific region. Through extensive research and multi-stakeholder interviews, done in partnership with ANSEA, this paper proposes 5 practical recommendations for policy-makers to enable better patient access & funding, with a practical comprehensive fit-for-purpose value assessment framework for in-vitro diagnostics (IVDs), in the case of cardiovascular diseases (coronary artery disease and heart failure).